
Ticarsh 60mg Tablet
Marketer
Kasdap Healthcare Pvt Ltd
Salt Composition
Ticagrelor (60mg)
Overview Ticarsh 60mg Tablet
CardioGuard 60mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the development of dangerous blood clots within blood vessels, thus lowering the risk of stroke or heart attack in patients with cardiac conditions. CardioGuard 60mg is also indicated for individuals who've recently experienced a heart attack, severe angina (chest pain), or undergone coronary stenting. Its use helps prevent subsequent cardiac events, such as further heart attacks, strokes, or clot formation within stents. Concomitant use with aspirin, another antiplatelet medication, will be prescribed by your physician. CardioGuard 60mg can be administered with or without food, consistently at the same time daily. Continuous use is crucial, even in the absence of symptoms, as discontinuation elevates the risk of recurrent cardiac events. The most prevalent adverse effect is bleeding, potentially prolonging clotting time following injury. While generally mild and self-limiting, persistent bleeding or worsening should be reported to your doctor. Similarly, some patients may experience mild shortness of breath, typically resolving with continued treatment; report any persistent or worsening shortness of breath. CardioGuard 60mg is contraindicated in patients with active internal bleeding (e.g., stomach ulcers, cerebral hemorrhage) or liver disease. Disclose any such conditions to your doctor prior to commencing treatment.
Uses of Ticarsh 60mg Tablet
Averting cardiovascular events such as heart attack and stroke
Major Benefits of Ticarsh 60mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 60mg Ticarsh tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, however, consistent daily timing is recommended.
Common Side effects of Ticarsh 60mg Tablet:
- Bleeding
- Breathlessness
How to use Ticarsh 60mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticarsh 60mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Ticarsh 60mg Tablet works:
Ticarsh 60mg tablets inhibit platelet aggregation, a process crucial in blood clot formation. This antiplatelet action reduces the risk of cardiovascular events such as heart attack and stroke.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Ticarsh 60mg tablets with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Ticarsh 60mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against any possible risks prior to prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Ticarsh 60mg Tablet with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticarsh 60mg Tablet.
KidneySAFE IF PRESCRIBED
Ticarsh 60mg tablets pose no safety concerns for individuals with kidney impairment; dosage modification is unnecessary. Data regarding Ticarsh 60mg tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Ticarsh 60mg Tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates the use of Ticarsh 60mg Tablets; physician consultation is advised.
What if you forget to take Ticarsh 60mg Tablet :
Should you forget to take your Ticarsh 60mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticarsh 60mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |
